WALTER J. MEYER III, M.D.; JOHN R. GILL Jr., M.D., F.A.C.P.; FREDERIC C. BARTTER, M.D.
A prevalence of hyperuricemia of 50% and of acute gouty arthritis of 20% has been observed in a group of patients with Bartter's syndrome. All patients except one presented initially with complaints unrelated to uric acid metabolism. The cause of their hyperuricemia and subnormal clearance of uric acid is unexplained. Systemic alkalosis, a prominent feature of Bartter's syndrome, can decrease the clearance of uric acid and may contribute to the hyperuricemia and gout that have been observed. Physicians should be aware of the possibility of gout as a clinical complication of Bartter's syndrome and of the inhibitory effects of alkalosis on urate clearance.
Learn more about subscription options.
Register Now for a free account.
MEYER WJ, GILL JR, BARTTER FC. Gout as a Complication of Bartter's Syndrome: A Possible Role for Alkalosis in the Decreased Clearance of Uric Acid. Ann Intern Med. 1975;83:56–59. doi: 10.7326/0003-4819-83-1-56
Download citation file:
Published: Ann Intern Med. 1975;83(1):56-59.
Adrenal Disorders, Endocrine and Metabolism, Gout, Rheumatology.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only